ADOPTIVE IMMUNOTHERAPY FOR EPITHELIAL OVARIAN CANCER USING T CELLS SIMULTANEOUSLY TARGETED TO TUMOR AND TUMOR-ASSOCIATED MACROPHAGES
$-33,839FY2014Department of DefenseDOD
King'S College London, London
Investigators
View source on USAspending →ADOPTIVE IMMUNOTHERAPY FOR EPITHELIAL OVARIAN CANCER USING T CELLS SIMULTANEOUSLY TARGETED TO TUMOR AND TUMOR-ASSOCIATED MACROPHAGES · GrantIndex